Article
Pfizer's COVID antiviral Paxlovid gains full US approval
Rating:
0.0
Views:
63
Likes:
1
Library:
1
The U.S. Food and Drug Administration on Thursday granted full approval to Pfizer's oral antiviral COVID-19 treatment Paxlovid, clearing the way for the drugmaker to sell it at market rates once U.S. government supplies dwindle.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value